1. Home
  2. VERA vs OBDE Comparison

VERA vs OBDE Comparison

Compare VERA & OBDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • OBDE
  • Stock Information
  • Founded
  • VERA 2016
  • OBDE 2020
  • Country
  • VERA United States
  • OBDE United States
  • Employees
  • VERA N/A
  • OBDE N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • OBDE
  • Sector
  • VERA Health Care
  • OBDE
  • Exchange
  • VERA Nasdaq
  • OBDE NYSE
  • Market Cap
  • VERA 2.5B
  • OBDE 1.8B
  • IPO Year
  • VERA 2021
  • OBDE N/A
  • Fundamental
  • Price
  • VERA $42.01
  • OBDE $14.55
  • Analyst Decision
  • VERA Strong Buy
  • OBDE Buy
  • Analyst Count
  • VERA 9
  • OBDE 1
  • Target Price
  • VERA $53.56
  • OBDE $16.00
  • AVG Volume (30 Days)
  • VERA 683.6K
  • OBDE 180.0K
  • Earning Date
  • VERA 11-07-2024
  • OBDE 11-06-2024
  • Dividend Yield
  • VERA N/A
  • OBDE 4.03%
  • EPS Growth
  • VERA N/A
  • OBDE N/A
  • EPS
  • VERA N/A
  • OBDE N/A
  • Revenue
  • VERA N/A
  • OBDE N/A
  • Revenue This Year
  • VERA N/A
  • OBDE N/A
  • Revenue Next Year
  • VERA N/A
  • OBDE N/A
  • P/E Ratio
  • VERA N/A
  • OBDE N/A
  • Revenue Growth
  • VERA N/A
  • OBDE N/A
  • 52 Week Low
  • VERA $9.68
  • OBDE $13.60
  • 52 Week High
  • VERA $50.78
  • OBDE $16.80
  • Technical
  • Relative Strength Index (RSI)
  • VERA 52.57
  • OBDE 55.89
  • Support Level
  • VERA $39.22
  • OBDE $14.16
  • Resistance Level
  • VERA $50.00
  • OBDE $14.65
  • Average True Range (ATR)
  • VERA 2.41
  • OBDE 0.20
  • MACD
  • VERA 0.24
  • OBDE 0.01
  • Stochastic Oscillator
  • VERA 28.53
  • OBDE 80.33

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About OBDE BLUE OWL CAPITAL CORP III

Blue Owl Capital Corp III is focused on originating and making loans to, and debt and equity investments in middle-market companies based predominantly in the United States. Its objective is to generate current income and, to a lesser extent, capital appreciation by targeting investment opportunities with favorable risk-adjusted returns. The company invests in senior secured or unsecured loans, subordinated loans or mezzanine loans and, to a lesser extent, equity and equity-related securities including warrants, preferred stock and similar forms of senior equity, which may or may not be convertible into a portfolio company's common equity.

Share on Social Networks: